-+ 0.00%
-+ 0.00%
-+ 0.00%

Jianmin Group (600976.SH): Claribolol Ointment approved for listing

Zhitongcaijing·09/03/2026 10:41:05
Listen to the news

Zhitong Finance App News, Jianmin Group (600976.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” approved and issued by the State Drug Administration, and the Claribolol ointment developed by the company was approved for listing. Indications: Used for topical topical treatment of patients with mild to moderate atopic dermatitis aged 3 months and above.